Unresectable Hepatocellular Carcinoma Clinical Trials in Beijing, Beijing Municipality
2 recruitingBeijing, Beijing Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Anti-PD-1/PD-L1 Combined With Anti-angiogenic Agents as First-line Treatment for Unresectable HCC
Unresectable Hepatocellular Carcinoma
Peking University Cancer Hospital & Institute111 enrolled1 locationNCT06360042
Recruiting
Phase 2
Phase 2 Study of SBRT Plus Tislelizumab and Regorafenib in Unresectable or Oligometastatic HCC
Unresectable Hepatocellular CarcinomaOligometastatic Disease
Peking University Cancer Hospital & Institute39 enrolled1 locationNCT05917431